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Abstract: Protein encoding genes constitute a small fraction of mammalian genomes. In addition to 9 
the protein coding genes, there are other functional units within the genome that are transcribed, 10 
but not translated into protein, the so called non-coding RNAs. There are many types of non-coding 11 
RNAs that have been identified and shown to have important roles in regulating gene expression 12 
either at the transcriptional or post-transcriptional level. A number of recent studies have 13 
highlighted that dietary manipulation in mammals can influence the expression or function of a 14 
number of classes of non-coding RNAs that contribute to the protein translation machinery. The 15 
identification of protein translation as a common target for nutritional regulation underscores the 16 
need to investigate how this may mechanistically contribute to phenotypes and diseases that are 17 
modified by nutritional intervention. Finally, we describe the state of the art and the application of 18 
emerging ‘-omics’ technologies to address the regulation of protein translation in response to diet. 19 
Keywords: non-coding RNA; gene-diet interaction; omics, epigenetics, epitranscriptome, RNA 20 
modifications, ribosome, protein translation  21 
 22 
 23 
1. Introduction 24 
There is an increasing body of evidence to suggest that nutrition can alter gene expression, with 25 
genes that encode components of the cellular protein translation machinery representing a common 26 
target (for example: tRNA [1-5], ribosomal protein [6,7], rRNA [8-14]). The targeting of this pathway 27 
is perhaps not surprising given that it is the most energy-consuming cellular process and therefore 28 
needs to be tightly coupled to energy availability. Here we will discuss the recent evidence from 29 
animal models for nutritional modulation of the non-coding RNA elements that contribute to this 30 
machinery and the implications of this for associated phenotypes, namely obesity, insulin resistance 31 
and ‘metabolic disease’ (Figure 1).  32 
 33 
We focus on the factors which contribute to the RNA structural components of the ribosome 34 
(ribosomal RNA; rRNA) and the small RNAs which direct its site-specific post-transcriptional 35 
modification (small nucleolar RNAs; snoRNAs). In addition to ribosomal components, we discuss 36 
transfer RNAs (tRNAs), which recruit the amino acids to the site of polypeptide synthesis and their 37 
functional cleavage products (tRNA fragments).   38 
 39 
Finally, we address the requirement for further investigation into how nutritional modulation 40 
of these components might contribute to disease and outline how the application of a range of 41 
recently developed ‘-omics’ technologies can be applied to elucidate how nutrition can interact with 42 
underlying genetic variation to modulate gene expression at both transcriptional and post-43 
transcriptional levels. 44 
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2. Nutritionally sensitive non-coding RNA species that contribute to the regulation of protein 45 
translation 46 
 47 
Figure 1. Summary of current evidence for dietary modulation of non-coding RNAs that contribute 48 
to the protein translation machinery. Dietary interventions have specific effects depending on the 49 
developmental period (indicated with reference to intergenerational life cycle by the solid bar). 50 
Studies of protein restriction are indicated in the red outlined panel. Studies of obesity/high fat diet 51 
are indicated in the green panel. Measured phenotypes are indicated along with the associated non-52 
coding RNA changes (italics) (rDNA, ribosomal DNA; tRNA, transfer RNA; snoRNA, small nucleolar 53 
RNA; miRNA, microRNA). 54 
2.1. Ribosomal RNA (rRNA) 55 
rRNAs encoded by the ribosomal DNA (rDNA) are an indispensable structural and catalytic 56 
component of the ribosome in which they assist selection of mRNA molecules to be translated and 57 
catalyse polypeptide bond formation of the amino acids delivered by tRNAs during protein 58 
translation [15]. Mammalian genomes encode hundreds of copies of the rDNA operon, arranged in 59 
tandem arrays on specific chromosomes (for example: 13, 14, 15, 21, and 22 in human) [16], yet the 60 
precise organisation and sequence of these genes is unknown and not included in current genome 61 
assemblies. Transcription of rRNA is prolific, accounting for ~35% of the total in the cell [17]. 62 
However, only a fraction of the rDNA copies within a cell are actively transcribed due to epigenetic 63 
regulation [18-22]. Active copies of rDNA display euchromatic characteristics such as little DNA 64 
methylation and the active histone modifications, H3K4 methylation and H3K9 acetylation. In 65 
contrast, silent copies of rDNA are in compact chromatin associated with DNA methylation and 66 
repressive histone modifications H3K9 and H4K20 methylation [16]. rDNA copies within a single 67 
genome are genetically polymorphic and the number of copies varies between individuals [23-25]. 68 
Little is known about how genetic variation within the rRNA genes may influence ribosome function.  69 
 70 
Transcription of rDNA is tightly coupled to both the general cellular metabolism and specific 71 
environmental challenges [12]. Stress conditions including ageing, cancer and viral infection are 72 
associated with reduced rRNA transcription [26]. On the contrary, upregulation of rRNA expression 73 
can be achieved by growth factor stimulation [12,26]. Repression of rRNA was also observed in 74 
response to different dietary interventions including glucose starvation [8-10] and high fat diet [11].  75 
Mutation of genes which encode proteins involved in rRNA biogenesis have been implicated in a 76 
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number of human diseases [27]. Given that the rate of ribosome production and thus protein 77 
synthesis are tightly coupled to cellular growth and proliferation, exquisite control of rRNA 78 
expression, the first step of ribosome biogenesis is therefore fundamental for these processes.  79 
 80 
Recently, studies in mice have demonstrated rDNA is a genomic target of early life nutritional 81 
insult which may contribute to lifelong phenotypic consequences. Altered DNA methylation and 82 
transcription of the rRNA genes in offspring of dams fed a protein restricted diet during particular 83 
developmental windows has been shown [13,14]. Diet-induced DNA methylation of rDNA in 84 
offspring of mice subjected to protein restriction from conception to weaning was exclusive to a 85 
subset of rDNA copies within the genome that could be distinguished by a genetic polymorphism 86 
within the rDNA promoter [14]. The extent of DNA methylation at this genetically distinct subset of 87 
rDNA correlated negatively with the amount of growth restriction as measured by weaning weight 88 
induced by the diet [14]. These mice also displayed reduced spontaneous locomotor activity and 89 
reduced glucose-stimulated insulin secretion [14]. Given that birth weight is associated with altered 90 
cardiovascular risk factors [28-31] as well as various type of cancers later in life [32-35], it will be 91 
intriguing to establish if there is a functional link between the extent of diet induced rDNA 92 
methylation and disease risk in this model. Importantly, increased rDNA variant-specific rDNA 93 
methylation was also observed in response to both a high fat and an obesogenic ‘Western’ diet from 94 
conception to weaning in the same study [14]. The increased rDNA methylation in this model was 95 
validated in an independent study, which further identified that this response was specific to a 96 
discreet period of protein restriction in early life as continual exposure and exclusively post-weaning 97 
exposure did not produce a similar increase in rDNA methylation [5]. These studies identify an 98 
interaction between the rDNA genotype and the early life environment which correlates with a 99 
distinct phenotypic outcome [5,14]. These results are interesting when interpreted in the light of 100 
previous studies showing similar mouse models resulting in altered metabolic phenotypes and 101 
increased cardiometabolic disease in adulthood [36-38].  102 
 103 
2.2. Small nucleolar RNAs (snoRNA) 104 
SnoRNAs are short non-coding RNA molecules of around 60-300 nucleotides in length which 105 
are found mainly in the nucleolus. The well-conserved snoRNA have been reported in a broad variety 106 
of organisms [39,40]. The central function of snoRNAs is direction of 2’-O-ribose methylation and 107 
pseudouridylation of specific rRNA nucleotides [39]. These modifications are important for correct 108 
folding and structural stabilisation of the rRNA [41] and the interaction between rRNAs and other 109 
components of the translational machinery [42] as required for normal ribosome function [43,44]. 110 
Outside the nucleoli, snoRNA fragments have been reported to act as precursors for functional 111 
miRNA [45-48] and regulators of alternative splicing [49]. Moreover, upregulation of snoRNAs has 112 
also been reported under various stress conditions [39] and to be dysregulated in cancers [39,50,51], 113 
supporting the physiological relevance of snoRNA function.  114 
 115 
Although direct evidence connecting nutrition to changes in snoRNA expression are limited, a 116 
recent study has shown that mice fed a protein-restricted diet from weaning into adulthood have 117 
altered snoRNA composition within their sperm small RNA complement [5]. This, together with the 118 
suggestion that specific snoRNA-targeted sites in the rRNA are modified on some, but not all 119 
molecules, suggests that changes in snoRNA expression could alter the modification profile of rRNA 120 
[52]. Alterations in rRNA modification have been implicated in influencing ribosome function [53]. 121 
Intriguingly, in lower model organisms, deletion of the rRNA modifying enzyme, NSUN5 induces 122 
alterations in protein translation and organism longevity that only become apparent after a 123 
nutritional insult [54]. In mice, the rRNA modifying enzyme NML was shown to be associated with 124 
high fat diet-induced obesity [11]. These studies indicate both the importance and convergence of 125 
control of protein translation and nutritional modulation of health.  126 
 127 
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2.3. Transfer RNA (tRNA) 128 
Transfer RNAs (tRNAs) are the most abundant small non-coding RNA molecules making up 4–129 
10% of all cellular RNA [55]. They are well known for their role in delivering amino acids to the 130 
ribosome to decode the genetic information on the messenger RNA (mRNA) for protein synthesis 131 
[56]. Beyond this canonical role, tRNAs have also been found to perform additional functions 132 
including regulation of global protein synthesis under amino acid starvation [57].  133 
 134 
Recent studies using high-throughput sequencing have identified small non-coding RNA 135 
fragments that are derived from tRNAs [58-60]. These tRNA fragments are generated from site-136 
specific cleavage of precursor or mature tRNAs by specific ribonucleases and are divided into distinct 137 
categories and sub-categories based on their origin, length and mapping positions [57,61-63]. One 138 
class, tRNA-derived fragments (tRFs) are small RNAs of about 14-30 nt in length that map to the ends 139 
or the internal region of precursor or mature tRNA [63,64]. A second class of tRNA fragment are 140 
tRNA halves which are generated by specific cleavage in the anticodon loop of a mature tRNA 141 
molecule to produce 30-40 nt 5’ and 3’ fragments. These tRNA fragments display cell-type specific 142 
expression and have important functions, including the regulation of translation through 143 
mechanisms that are distinct to the role of mature tRNAs in amino acid delivery [63-65]. It is however 144 
noteworthy that these tRNA fragments are quite heterogeneous with the multiple possible cleavage 145 
sites on the tRNA molecule and the involvement of different tRNA isoaccetpors and isodecoders.  146 
 147 
Numerous tRNA fragment types are elevated under stress conditions and alteration in their 148 
abundance has been associated with various human diseases including cancer and 149 
neurodegenerative diseases [62,64]. A number of recent studies based on rodent models have shown 150 
adult nutrition influences the relative abundance of specific tRNA fragments in sperm and that this 151 
may influence post-fertilisation gene expression, development, and adult metabolic phenotypes in 152 
offspring [2-5]. In the interest of this review, we will focus on reviewing findings involving 5’ tRNA 153 
halves which were shown to be associated with dietary intervention.   154 
 155 
Sharma et al. showed that sperm derived from male mice fed a low protein diet display a 2-3-156 
fold increase in multiple types of 5’ tRNA halves (most notably 5’ halves of tRNA-Gly-157 
CCC/TCC/GCC, Lys-CTT and His-GTG) and use 5’ halves of tRNA-glycine-GCC as an example [2]. 158 
Inhibition of 5’ tRNA-glycine-GCC halves in mouse embryonic stem cells correlated with 159 
upregulation of about 70 genes that are naturally highly expressed in pre-implantation embryos [2]. 160 
Interestingly, injection of the small RNA fraction purified from sperm of low-protein fed males 161 
(containing increased 5’ tRNA-glycine-GCC halves) reduced the transcript abundance of these same 162 
targets in normal two-cell embryos [2]. Adult offspring of these low-protein fed males had altered 163 
expression of the transcript encoding a cholesterol biosynthesis enzyme (squalene epoxidase) in the 164 
liver [2]. This suggests a mechanistic role for 5’ tRNA-glycine-GCC halves in regulating transcript 165 
abundance in early embryogenesis in a manner which might influence cholesterol metabolism in the 166 
adult. 167 
 168 
Altered expression profile of a subset of 5’ tRNA halves were also observed in the sperm of mice fed 169 
a high-fat diet [3]. These 5’ tRNA halves displayed altered RNA modifications, including an increase 170 
in 5-methylcytidine (m5C) [3]. This specific tRNA modification is mediated by an enzyme (DNMT2), 171 
which has been previously implicated in genetic deletion studies as having a role in paternal 172 
transmission of putative ‘epigenetic’ phenotypes in mice [66]. Injection of small RNA fractions from 173 
the sperm of high-fat fed males into normal zygotes correlated with downregulation of metabolic 174 
pathway genes in eight-cell embryos and blastocysts [3]. Adult offspring derived from this technique 175 
had altered regulation of glucose homeostasis associated with downregulation of genes involved in 176 
metabolic pathways in pancreatic islets [3]. Another independent study also found that offspring of 177 
obese sires have no overt phenotypes unless fed a high saturated fat and sugar ‘Western diet’, which 178 
led to male offspring having exacerbated fat deposition, glucose intolerance, hyperinsulinemia and 179 
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hepatic steatosis [4]. Interestingly, these first generation offspring which were not fed a Western diet 180 
and appeared metabolically normal had altered miRNA distribution and increased expression of 5’ 181 
tRNA halves (derived from tRNA-Gly-GCC, Glu-CTC, Val-CAC and His-GTG) in their sperm and 182 
produced second generation offspring that were also hypersensitive to Western diet induced 183 
metabolic disease [4].  184 
 185 
Taken together, these data indicate that gene regulation in the early embryo can be affected by 186 
paternal diet via sperm tRNA fragments, with potential consequences for embryonic development 187 
and lifetime phenotypes as a result. The molecular mechanisms for how tRNA fragments mediate 188 
these alterations in gene expression are still elusive. 189 
 190 
3. ‘Omics’ approaches 191 
Increasingly, there are a diverse array of ‘-omics’ approaches available to profile the molecular 192 
landscape of choice. These approaches are characterised by being, to some extent, ‘hypothesis 193 
neutral,’ that is, to capture all changes that occur in response to an exposure, rather than looking at a 194 
particular pre-determined molecular target.  195 
 196 
High-throughput sequencing approaches have been developed to profile nucleic acid sequences 197 
(DNA and RNA) in a quantitative manner. With the increased cost-effectiveness of sequencing, 198 
whole-genome sequencing now allows for the high resolution mapping of inter-individual genetic 199 
variation. However, understanding the functional consequences of sequence variation and how it 200 
interacts with environmental factors such as nutrition requires correlating genomic sequence 201 
variation with changes in the expression, structure and function of gene products. Furthermore, these 202 
relationships are likely to be both cell type and exposure dependent.  203 
 204 
RNA sequencing is a well-established technique and has greatly assisted with understanding 205 
how sequence variants can influence the level of transcripts (either mRNA, lncRNA or small RNAs), 206 
leading to the identification of expression quantitative trait loci (eQTLs) [67]. However, the level of 207 
mRNA for a particular gene does not necessarily reflect the amount of corresponding protein [68]. 208 
Given that the ribosome and other factors involved in the regulation of protein translation have been 209 
identified as common targets for nutritional modulation, here we will discuss recently developed 210 
techniques that can be used to profile factors which may influence ribosome structure and function, 211 
as well as protein translation. Integration of these techniques with well-established DNA and RNA 212 
sequencing approaches will be key to creating a more complete understanding of how nutrition and 213 
other environmental factors interact with genetic variation to contribute to phenotypes. 214 
 215 
3.1. Understanding the consequences of altered expression and post-transcriptional modification of non-coding 216 
RNA components of the protein translation machinery 217 
As discussed above, there is evidence that both snoRNA expression and tRNA modification and 218 
fragmentation can be altered by diet in mice [2-5], implying that both rRNA and tRNA post-219 
transcriptional modifications are nutrient sensitive. tRNA and rRNA are the most highly modified 220 
class of RNAs with about 17% and 2% of their nucleotides being modified, respectively [53,69]. These 221 
modifications can impact translational control and are implicated in human diseases [53,55].  222 
 223 
Some examples in organisms ranging from yeast to human highlight that post-transcriptional 224 
modification of rRNA can impact ribosome function in protein translation and may contribute to 225 
regulatory functions. The importance of rRNA modifications is demonstrated by the genetic loss of 226 
multiple snoRNAs which direct site-specific rRNA modifications causing altered translation 227 
efficiency [70-72], impaired stop codon termination and shifting the translated reading frame [44]. 228 
While other changes in rRNA pseudouridylation influence translation initiation from internal 229 
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ribosome entry sites (IRES) on a specific subset of mRNAs by altering the affinity of the ribosome for 230 
these mRNA structures [42,73,74]. In the case of the EMG1 gene mutation that underlies the fatal 231 
Bowen-Conradi syndrome [75,76], reduced psuedouridine methylation is associated with a failure of 232 
ribosome small subunit assembly [77,78]. 233 
 234 
tRNA post-transcriptional modifications have also been shown to influence protein translation. 235 
Modification of uridine at the wobble position (nucleoside 34) modulates the decoding preference of 236 
tRNAs [79], with loss of this modification leading to a reduced rate of protein translation [80]. A range 237 
of tRNA modifications have been genetically linked to developmental and metabolic disease. 238 
Mutation of NSUN2 which methylates cytosine-5 of tRNAs is associated with microcephaly in 239 
humans and mice [81], while mutation of CDKAL1 which catalyses the 2‑methylthio-N6-240 
threonylcarbamoyladenosine (ms2t6A) modification of A37 in tRNA-Lys-UUU is associated with 241 
increased risk of type 2 diabetes mellitus in humans and mice [82-84].  242 
 243 
These few examples highlight that RNA modifications to the rRNA and tRNA contribute an 244 
additional and possibly regulatory mechanism to translational regulation. However, getting a 245 
complete picture of the landscape of these modifications is currently limited by the lack of 246 
methodologies available to comprehensively map RNA modifications. Here we will discuss 247 
techniques to map some specific modifications conferred through snoRNAs and modifications 248 
known to be prevalent in tRNAs. Identifying the sites and prevalence of these modifications is an 249 
important step in understanding their functional significance. 250 
 251 
Pseudouridine is a highly abundant modified nucleoside found in both rRNA (where its site-252 
specific modification involves the H/ACA family of snoRNAs) and in tRNA [85]. Pseudouridylation 253 
in rRNA contributes to translational fidelity and regulation of the translation of specific transcripts 254 
that contain internal ribosome entry sites and can undergo cap-independent translation [73]. 255 
Recently, two methods for the profiling of pseudouridine have been developed, both relying on the 256 
stable addition of a chemical adduct to pseudouridine which causes premature termination of the 257 
reverse transcriptase during subsequent library preparation for high-throughput sequencing. These 258 
methods allow for the identification of modified sites, as the termination of the sequencing read is 259 
significantly enriched at sites of modification compared to libraries prepared from untreated RNA 260 
[85,86]. 261 
 262 
The other snoRNA-mediated rRNA modification is ribose 2’-O-methylation (via box C/D 263 
snoRNAs), which has also recently been implicated in modulating the capacity for ribosomes to 264 
initiate translation from internal ribosome entry sites rather than the m7G-cap [87]. A comparable 265 
technique for non-biased mapping of ribose 2’-O-methylation sites has been developed. This 266 
technique relies on the resistance of the phosphodiester bond 3’ to the site of modification to random 267 
alkaline induced fragmentation. Protection from fragmentation leads to under-representation of 268 
sequencing reads that start or end at sites of ribose 2’-O-methylation [88]. 269 
 270 
tRNA modifications have been implicated in regulating the level of fragmentation in response 271 
to nutritional insults [3]. One of these modifications is 5-methylcytidine [89]. A robust methodology 272 
for the quantitative mapping of this modification in RNA has been developed and is akin to busulfite-273 
based profiling of 5-methylcytosine in DNA [90]. This technique relies on the resistance of 5-methyl 274 
cytidine residues to deamination by sodium bisulfite, while non-methylated residues are converted. 275 
After reverse transcription and library preparation, methylated residues are read as cytosine, 276 
whereas unmethylated residues are read as thymine. This is used to determine the methylation status 277 
of sites after mapping back to the genome. 278 
 279 
There are more than 150 RNA modifications that have been identified, each with a unique set of 280 
biochemical properties [69]. So far, only a limited number of modifications have been successfully 281 
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profiled using a high-throughput sequencing based, genome-wide assay. While the techniques that 282 
have been developed represent a significant technological advancement by permitting the 283 
identification of novel sites of modification and the relative quantitation (i.e. the stoichiometry), they 284 
cannot determine the absolute level of modification or the prevalence of co-modification on a single 285 
RNA molecule. The diversity of RNA modifications may mean that obtaining a complete picture of 286 
the RNA modification landscape may remain intractable. However, it will be interesting to see how 287 
improvements in the capacity for direct RNA sequencing technologies to distinguish RNA 288 
modifications will impact this field in the future [91].  289 
 290 
3.2. Understanding the regulation of protein translation by nutrition 291 
We and others have previously shown that dietary nutrition can influence the expression of 292 
distinct genetic variants of the core protein translation machinery [2,5,14]. However, how these effects 293 
impact on the activity of the translational machinery is unknown. To understand the functional 294 
consequences of these diet-induced effects, it is necessary to profile the translatome. The translatome 295 
refers to the entirety of mRNA in a cell that is being translated at a given moment and is inferred 296 
through an enrichment of specific mRNAs with ribosomes. Two unbiased, high throughput 297 
sequencing-based approaches have been developed to date. Both rely on the chemical cross-linking 298 
of ribosomes to the mRNA species that they are actively translating.  299 
 300 
Polysome profiling involves size-fractionating the cellular lysate and collecting fractions 301 
containing the small and large ribosome subunits, monosomes or polysomes. Highly translated 302 
mRNAs are engaged with multiple ribosomes and will be contained in the heavier polysome fraction.  303 
Poorly translated mRNA will be found in the other fractions. The RNA is then extracted from each 304 
fraction and used to prepare high-throughput sequencing libraries. The relative enrichment of 305 
specific mRNA species in each fraction compared to the non-fractionated input material is then 306 
determined [92].   307 
 308 
An alternative approach that provides higher resolution is ribosome profiling [93]. After cross-309 
linking, the resulting mRNA-ribosome complexes are digested with nucleases, such that only the 310 
regions of the mRNA that were bound to a ribosome are protected from degradation. These mRNA 311 
fragments are then purified and subjected to deep-sequencing. The density of ribosome footprints is 312 
calculated for each mRNA transcript and normalised to transcript length and abundance in the 313 
original sample.  314 
 315 
While translatome profiling technologies provide a snapshot, it is necessary to gain an 316 
understanding of how both genetic variation and nutritional interventions impact on the stable 317 
proteome and metabolic status. Quantitative mass-spectrometry based approaches exist to profile 318 
proteins or metabolites. The sensitivity of these techniques is ever-improving, permitting detection 319 
of an increasing proportion of the abundant components of any biological sample. The integration of 320 
these techniques in parallel to the application of the translatome profiling technologies described 321 
above is required to understand the link of changes in translational regulation to cellular and 322 
ultimately, organismal phenotypes. 323 
 324 
4. Summary and conclusions 325 
It is well established that both genes and environment contribute to health and disease. Here we 326 
highlight that the non-coding RNA molecules involved in protein translation present a common 327 
target of nutritional modulation. The study of such effects has so far been limited to animal models. 328 
This is because even when genetic background is controlled for (e.g. by using inbred mouse strains), 329 
the extent of genetic variation in some of these components (e.g. the genes encoding rRNA) is yet to 330 
be determined comprehensively. This is due to the genes encoding these elements of the protein 331 
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translation machinery being present in very high numbers within a single genome. This greatly 332 
reduces the ability to produce accurate assemblies of these genes using the relatively short-read 333 
sequencing technologies commonly applied to study genetic variation. As such, the extent of within 334 
and inter-individual genetic variation within these non-coding RNA is unknown. Even less is known 335 
how both genetic variation and nutritional modulation of these components impact on the regulation 336 
of protein translation.  337 
 338 
Elucidating nutritional regulation of the protein translation machinery will need to be driven by 339 
animal models in the shorter term due to the limitations of what is known regarding genetic variation 340 
within the key components. However, while long-read sequencing technologies hold the promise to 341 
resolve our capacity to map and then explore genetic diversity at these elements, a reverse function-342 
over-form approach can be undertaken simultaneously. Integration of the existing ‘-omics’ 343 
approaches to study the translatome and proteome will be useful in establishing just how 344 
nutritionally responsive post-transcriptional gene regulation is and what role it might have in 345 
directing phenotypes, particularly those associated with altered metabolic function, as indicated from 346 
studies to date. While most studies of gene-environment interactions (including the impact of 347 
nutrition) to date have focussed on classic ‘epigenetic’ markers associated with altered gene 348 
transcription (e.g. DNA methylation), it is highly likely that genetic variation within and nutritional 349 
regulation of the protein translational machinery will impact substantially on how an individual will 350 
respond to nutritional challenges phenotypically. Now that technology exists to explore these 351 
processes, we are posed with an exciting challenge that promises to increase our understanding of 352 
how nutrition modifies developmental outcomes and adult disease risk.  353 
 354 
Author Contributions: PPL and MLH contributed equally to the preparation of this review article. 355 
Funding: This work was funded by The Academy of Medical Sciences Springboard Award [SBF003\1026] and 356 
Royal Society Research Grant [RGS\R2\180202] to MLH.  357 
Conflicts of Interest:  The authors declare no conflict of interest.  358 
References 359 
 360 
1. Moir, R.D.; Willis, I.M. Regulation of pol III transcription by nutrient and stress signaling 361 
pathways. Biochim Biophys Acta 2013, 1829, 361-375, doi:10.1016/j.bbagrm.2012.11.001. 362 
2. Sharma, U.; Conine, C.C.; Shea, J.M.; Boskovic, A.; Derr, A.G.; Bing, X.Y.; Belleannee, C.; 363 
Kucukural, A.; Serra, R.W.; Sun, F., et al. Biogenesis and function of tRNA fragments during 364 
sperm maturation and fertilization in mammals. Science 2016, 351, 391-396, 365 
doi:10.1126/science.aad6780. 366 
3. Chen, Q.; Yan, M.; Cao, Z.; Li, X.; Zhang, Y.; Shi, J.; Feng, G.H.; Peng, H.; Zhang, X.; Zhang, 367 
Y., et al. Sperm tsRNAs contribute to intergenerational inheritance of an acquired metabolic 368 
disorder. Science 2016, 351, 397-400, doi:10.1126/science.aad7977. 369 
4. Cropley, J.E.; Eaton, S.A.; Aiken, A.; Young, P.E.; Giannoulatou, E.; Ho, J.W.K.; Buckland, 370 
M.E.; Keam, S.P.; Hutvagner, G.; Humphreys, D.T., et al. Male-lineage transmission of an 371 
acquired metabolic phenotype induced by grand-paternal obesity. Mol Metab 2016, 5, 699-372 
708, doi:10.1016/j.molmet.2016.06.008. 373 
5. Danson, A.F.; Marzi, S.J.; Lowe, R.; Holland, M.L.; Rakyan, V.K. Early life diet conditions the 374 
molecular response to post-weaning protein restriction in the mouse. BMC biology 2018, 16, 375 
51, doi:10.1186/s12915-018-0516-5. 376 
Nutrients 2018, 10, x FOR PEER REVIEW  9 of 15 
 
6. Kilberg, M.S.; Pan, Y.X.; Chen, H.; Leung-Pineda, V. Nutritional control of gene expression: 377 
how mammalian cells respond to amino acid limitation. Annu Rev Nutr 2005, 25, 59-85, 378 
doi:10.1146/annurev.nutr.24.012003.132145. 379 
7. Marion, R.M.; Regev, A.; Segal, E.; Barash, Y.; Koller, D.; Friedman, N.; O'Shea, E.K. Sfp1 is a 380 
stress- and nutrient-sensitive regulator of ribosomal protein gene expression. Proc Natl Acad 381 
Sci U S A 2004, 101, 14315-14322, doi:10.1073/pnas.0405353101. 382 
8. Murayama, A.; Ohmori, K.; Fujimura, A.; Minami, H.; Yasuzawa-Tanaka, K.; Kuroda, T.; Oie, 383 
S.; Daitoku, H.; Okuwaki, M.; Nagata, K., et al. Epigenetic control of rDNA loci in response 384 
to intracellular energy status. Cell 2008, 133, 627-639, doi:10.1016/j.cell.2008.03.030. 385 
9. Kumazawa, T.; Nishimura, K.; Kuroda, T.; Ono, W.; Yamaguchi, C.; Katagiri, N.; Tsuchiya, 386 
M.; Masumoto, H.; Nakajima, Y.; Murayama, A., et al. Novel nucleolar pathway connecting 387 
intracellular energy status with p53 activation. J Biol Chem 2011, 286, 20861-20869, 388 
doi:10.1074/jbc.M110.209916. 389 
10. Yang, L.; Song, T.; Chen, L.; Kabra, N.; Zheng, H.; Koomen, J.; Seto, E.; Chen, J. Regulation of 390 
SirT1-nucleomethylin binding by rRNA coordinates ribosome biogenesis with nutrient 391 
availability. Mol Cell Biol 2013, 33, 3835-3848, doi:10.1128/MCB.00476-13. 392 
11. Oie, S.; Matsuzaki, K.; Yokoyama, W.; Tokunaga, S.; Waku, T.; Han, S.I.; Iwasaki, N.; Mikogai, 393 
A.; Yasuzawa-Tanaka, K.; Kishimoto, H., et al. Hepatic rRNA transcription regulates high-394 
fat-diet-induced obesity. Cell Rep 2014, 7, 807-820, doi:10.1016/j.celrep.2014.03.038. 395 
12. Kusnadi, E.P.; Hannan, K.M.; Hicks, R.J.; Hannan, R.D.; Pearson, R.B.; Kang, J. Regulation of 396 
rDNA transcription in response to growth factors, nutrients and energy. Gene 2015, 556, 27-397 
34, doi:10.1016/j.gene.2014.11.010. 398 
13. Denisenko, O.; Lucas, E.S.; Sun, C.; Watkins, A.J.; Mar, D.; Bomsztyk, K.; Fleming, T.P. 399 
Regulation of ribosomal RNA expression across the lifespan is fine-tuned by maternal diet 400 
before implantation. Biochim Biophys Acta 2016, 1859, 906-913, 401 
doi:10.1016/j.bbagrm.2016.04.001. 402 
14. Holland, M.L.; Lowe, R.; Caton, P.W.; Gemma, C.; Carbajosa, G.; Danson, A.F.; Carpenter, 403 
A.A.; Loche, E.; Ozanne, S.E.; Rakyan, V.K. Early-life nutrition modulates the epigenetic state 404 
of specific rDNA genetic variants in mice. Science 2016, 353, 495-498, 405 
doi:10.1126/science.aaf7040. 406 
15. Noller, H.F. The parable of the caveman and the Ferrari: protein synthesis and the RNA 407 
world. Philosophical transactions of the Royal Society of London. Series B, Biological sciences 2017, 408 
372, doi:10.1098/rstb.2016.0187. 409 
16. McStay, B.; Grummt, I. The epigenetics of rRNA genes: from molecular to chromosome 410 
biology. Annu Rev Cell Dev Biol 2008, 24, 131-157, 411 
doi:10.1146/annurev.cellbio.24.110707.175259. 412 
17. Moss, T.; Langlois, F.; Gagnon-Kugler, T.; Stefanovsky, V. A housekeeper with power of 413 
attorney: the rRNA genes in ribosome biogenesis. Cell Mol Life Sci 2007, 64, 29-49, 414 
doi:10.1007/s00018-006-6278-1. 415 
18. Santoro, R.; Li, J.; Grummt, I. The nucleolar remodeling complex NoRC mediates 416 
heterochromatin formation and silencing of ribosomal gene transcription. Nat Genet 2002, 32, 417 
393-396, doi:10.1038/ng1010. 418 
Nutrients 2018, 10, x FOR PEER REVIEW  10 of 15 
 
19. Zhou, Y.; Santoro, R.; Grummt, I. The chromatin remodeling complex NoRC targets HDAC1 419 
to the ribosomal gene promoter and represses RNA polymerase I transcription. EMBO J 2002, 420 
21, 4632-4640. 421 
20. Santoro, R.; Grummt, I. Epigenetic mechanism of rRNA gene silencing: temporal order of 422 
NoRC-mediated histone modification, chromatin remodeling, and DNA methylation. Mol 423 
Cell Biol 2005, 25, 2539-2546, doi:10.1128/MCB.25.7.2539-2546.2005. 424 
21. Santoro, R. The silence of the ribosomal RNA genes. Cell Mol Life Sci 2005, 62, 2067-2079, 425 
doi:10.1007/s00018-005-5110-7. 426 
22. Mayer, C.; Schmitz, K.M.; Li, J.; Grummt, I.; Santoro, R. Intergenic transcripts regulate the 427 
epigenetic state of rRNA genes. Mol Cell 2006, 22, 351-361, doi:10.1016/j.molcel.2006.03.028. 428 
23. Tseng, H.; Chou, W.; Wang, J.; Zhang, X.; Zhang, S.; Schultz, R.M. Mouse ribosomal RNA 429 
genes contain multiple differentially regulated variants. PLoS One 2008, 3, e1843, 430 
doi:10.1371/journal.pone.0001843. 431 
24. Stults, D.M.; Killen, M.W.; Pierce, H.H.; Pierce, A.J. Genomic architecture and inheritance of 432 
human ribosomal RNA gene clusters. Genome Res 2008, 18, 13-18, doi:10.1101/gr.6858507. 433 
25. Parks, M.M.; Kurylo, C.M.; Dass, R.A.; Bojmar, L.; Lyden, D.; Vincent, C.T.; Blanchard, S.C. 434 
Variant ribosomal RNA alleles are conserved and exhibit tissue-specific expression. Science 435 
advances 2018, 4, eaao0665, doi:10.1126/sciadv.aao0665. 436 
26. Grummt, I. Life on a planet of its own: regulation of RNA polymerase I transcription in the 437 
nucleolus. Genes Dev 2003, 17, 1691-1702, doi:10.1101/gad.1098503R. 438 
27. Hannan, K.M.; Sanij, E.; Rothblum, L.I.; Hannan, R.D.; Pearson, R.B. Dysregulation of RNA 439 
polymerase I transcription during disease. Biochim Biophys Acta 2013, 1829, 342-360, 440 
doi:10.1016/j.bbagrm.2012.10.014. 441 
28. Suzuki, T.; Minami, J.; Ohrui, M.; Ishimitsu, T.; Matsuoka, H. Relationship between birth 442 
weight and cardiovascular risk factors in Japanese young adults. Am J Hypertens 2000, 13, 443 
907-913. 444 
29. Leeson, C.P.; Kattenhorn, M.; Morley, R.; Lucas, A.; Deanfield, J.E. Impact of low birth weight 445 
and cardiovascular risk factors on endothelial function in early adult life. Circulation 2001, 446 
103, 1264-1268. 447 
30. Huxley, R.; Owen, C.G.; Whincup, P.H.; Cook, D.G.; Rich-Edwards, J.; Smith, G.D.; Collins, 448 
R. Is birth weight a risk factor for ischemic heart disease in later life? The American journal of 449 
clinical nutrition 2007, 85, 1244-1250, doi:10.1093/ajcn/85.5.1244. 450 
31. Haas, G.M.; Liepold, E.; Schwandt, P. Low Birth Weight as a Predictor of Cardiovascular Risk 451 
Factors in Childhood and Adolescence? The PEP Family Heart Study. Int J Prev Med 2015, 6, 452 
121, doi:10.4103/2008-7802.172373. 453 
32. Fernandez-Twinn, D.S.; Ekizoglou, S.; Gusterson, B.A.; Luan, J.; Ozanne, S.E. Compensatory 454 
mammary growth following protein restriction during pregnancy and lactation increases 455 
early-onset mammary tumor incidence in rats. Carcinogenesis 2007, 28, 545-552, 456 
doi:10.1093/carcin/bgl166. 457 
33. Dusek, L.; Abrahamova, J.; Lakomy, R.; Vyzula, R.; Koptikova, J.; Pavlik, T.; Muzik, J.; Klimes, 458 
D. Multivariate analysis of risk factors for testicular cancer: a hospital-based case-control 459 
study in the Czech Republic. Neoplasma 2008, 55, 356-368. 460 
Nutrients 2018, 10, x FOR PEER REVIEW  11 of 15 
 
34. Stephansson, O.; Wahnstrom, C.; Pettersson, A.; Sorensen, H.T.; Tretli, S.; Gissler, M.; Troisi, 461 
R.; Akre, O.; Grotmol, T. Perinatal risk factors for childhood testicular germ-cell cancer: a 462 
Nordic population-based study. Cancer Epidemiol 2011, 35, e100-104, 463 
doi:10.1016/j.canep.2011.07.003. 464 
35. Walker, C.L.; Ho, S.M. Developmental reprogramming of cancer susceptibility. Nat Rev 465 
Cancer 2012, 12, 479-486, doi:10.1038/nrc3220. 466 
36. Watkins, A.J.; Ursell, E.; Panton, R.; Papenbrock, T.; Hollis, L.; Cunningham, C.; Wilkins, A.; 467 
Perry, V.H.; Sheth, B.; Kwong, W.Y., et al. Adaptive responses by mouse early embryos to 468 
maternal diet protect fetal growth but predispose to adult onset disease. Biol Reprod 2008, 78, 469 
299-306, doi:10.1095/biolreprod.107.064220. 470 
37. Fleming, T.P.; Watkins, A.J.; Sun, C.; Velazquez, M.A.; Smyth, N.R.; Eckert, J.J. Do little 471 
embryos make big decisions? How maternal dietary protein restriction can permanently 472 
change an embryo's potential, affecting adult health. Reprod Fertil Dev 2015, 27, 684-692, 473 
doi:10.1071/RD14455. 474 
38. Watkins, A.J.; Lucas, E.S.; Wilkins, A.; Cagampang, F.R.; Fleming, T.P. Maternal 475 
periconceptional and gestational low protein diet affects mouse offspring growth, 476 
cardiovascular and adipose phenotype at 1 year of age. PLoS One 2011, 6, e28745, 477 
doi:10.1371/journal.pone.0028745. 478 
39. Thorenoor, N.; Slaby, O. Small nucleolar RNAs functioning and potential roles in cancer. 479 
Tumour Biol 2015, 36, 41-53, doi:10.1007/s13277-014-2818-8. 480 
40. Kiss, T. Small nucleolar RNAs: an abundant group of noncoding RNAs with diverse cellular 481 
functions. Cell 2002, 109, 145-148. 482 
41. Watkins, N.J.; Bohnsack, M.T. The box C/D and H/ACA snoRNPs: key players in the 483 
modification, processing and the dynamic folding of ribosomal RNA. Wiley Interdiscip Rev 484 
RNA 2012, 3, 397-414, doi:10.1002/wrna.117. 485 
42. Basu, A.; Das, P.; Chaudhuri, S.; Bevilacqua, E.; Andrews, J.; Barik, S.; Hatzoglou, M.; Komar, 486 
A.A.; Mazumder, B. Requirement of rRNA methylation for 80S ribosome assembly on a 487 
cohort of cellular internal ribosome entry sites. Mol Cell Biol 2011, 31, 4482-4499, 488 
doi:10.1128/MCB.05804-11. 489 
43. Liu, B.; Liang, X.H.; Piekna-Przybylska, D.; Liu, Q.; Fournier, M.J. Mis-targeted methylation 490 
in rRNA can severely impair ribosome synthesis and activity. RNA Biol 2008, 5, 249-254. 491 
44. Baxter-Roshek, J.L.; Petrov, A.N.; Dinman, J.D. Optimization of ribosome structure and 492 
function by rRNA base modification. PLoS One 2007, 2, e174, 493 
doi:10.1371/journal.pone.0000174. 494 
45. Ender, C.; Krek, A.; Friedlander, M.R.; Beitzinger, M.; Weinmann, L.; Chen, W.; Pfeffer, S.; 495 
Rajewsky, N.; Meister, G. A human snoRNA with microRNA-like functions. Mol Cell 2008, 496 
32, 519-528, doi:10.1016/j.molcel.2008.10.017. 497 
46. Taft, R.J.; Glazov, E.A.; Lassmann, T.; Hayashizaki, Y.; Carninci, P.; Mattick, J.S. Small RNAs 498 
derived from snoRNAs. RNA 2009, 15, 1233-1240, doi:10.1261/rna.1528909. 499 
47. Scott, M.S.; Avolio, F.; Ono, M.; Lamond, A.I.; Barton, G.J. Human miRNA precursors with 500 
box H/ACA snoRNA features. PLoS Comput Biol 2009, 5, e1000507, 501 
doi:10.1371/journal.pcbi.1000507. 502 
Nutrients 2018, 10, x FOR PEER REVIEW  12 of 15 
 
48. Brameier, M.; Herwig, A.; Reinhardt, R.; Walter, L.; Gruber, J. Human box C/D snoRNAs 503 
with miRNA like functions: expanding the range of regulatory RNAs. Nucleic Acids Res 2011, 504 
39, 675-686, doi:10.1093/nar/gkq776. 505 
49. Kishore, S.; Khanna, A.; Zhang, Z.; Hui, J.; Balwierz, P.J.; Stefan, M.; Beach, C.; Nicholls, R.D.; 506 
Zavolan, M.; Stamm, S. The snoRNA MBII-52 (SNORD 115) is processed into smaller RNAs 507 
and regulates alternative splicing. Hum Mol Genet 2010, 19, 1153-1164, 508 
doi:10.1093/hmg/ddp585. 509 
50. Mannoor, K.; Liao, J.; Jiang, F. Small nucleolar RNAs in cancer. Biochim Biophys Acta 2012, 510 
1826, 121-128, doi:10.1016/j.bbcan.2012.03.005. 511 
51. Williams, G.T.; Farzaneh, F. Are snoRNAs and snoRNA host genes new players in cancer? 512 
Nat Rev Cancer 2012, 12, 84-88, doi:10.1038/nrc3195. 513 
52. Krogh, N.; Jansson, M.D.; Hafner, S.J.; Tehler, D.; Birkedal, U.; Christensen-Dalsgaard, M.; 514 
Lund, A.H.; Nielsen, H. Profiling of 2'-O-Me in human rRNA reveals a subset of fractionally 515 
modified positions and provides evidence for ribosome heterogeneity. Nucleic Acids Res 2016, 516 
44, 7884-7895, doi:10.1093/nar/gkw482. 517 
53. Sloan, K.E.; Warda, A.S.; Sharma, S.; Entian, K.D.; Lafontaine, D.L.; Bohnsack, M.T. Tuning 518 
the ribosome: The influence of rRNA modification on eukaryotic ribosome biogenesis and 519 
function. RNA Biol 2016, 10.1080/15476286.2016.1259781, 1-16, 520 
doi:10.1080/15476286.2016.1259781. 521 
54. Schosserer, M.; Minois, N.; Angerer, T.B.; Amring, M.; Dellago, H.; Harreither, E.; Calle-522 
Perez, A.; Pircher, A.; Gerstl, M.P.; Pfeifenberger, S., et al. Methylation of ribosomal RNA by 523 
NSUN5 is a conserved mechanism modulating organismal lifespan. Nature communications 524 
2015, 6, 6158, doi:10.1038/ncomms7158. 525 
55. Kirchner, S.; Ignatova, Z. Emerging roles of tRNA in adaptive translation, signalling 526 
dynamics and disease. Nat Rev Genet 2015, 16, 98-112, doi:10.1038/nrg3861. 527 
56. Rodnina, M.V.; Wintermeyer, W. The ribosome as a molecular machine: the mechanism of 528 
tRNA-mRNA movement in translocation. Biochem Soc Trans 2011, 39, 658-662, 529 
doi:10.1042/BST0390658. 530 
57. Raina, M.; Ibba, M. tRNAs as regulators of biological processes. Front Genet 2014, 5, 171, 531 
doi:10.3389/fgene.2014.00171. 532 
58. Kawaji, H.; Nakamura, M.; Takahashi, Y.; Sandelin, A.; Katayama, S.; Fukuda, S.; Daub, C.O.; 533 
Kai, C.; Kawai, J.; Yasuda, J., et al. Hidden layers of human small RNAs. BMC Genomics 2008, 534 
9, 157, doi:10.1186/1471-2164-9-157. 535 
59. Lee, Y.S.; Shibata, Y.; Malhotra, A.; Dutta, A. A novel class of small RNAs: tRNA-derived 536 
RNA fragments (tRFs). Genes Dev 2009, 23, 2639-2649, doi:10.1101/gad.1837609. 537 
60. Cole, C.; Sobala, A.; Lu, C.; Thatcher, S.R.; Bowman, A.; Brown, J.W.; Green, P.J.; Barton, G.J.; 538 
Hutvagner, G. Filtering of deep sequencing data reveals the existence of abundant Dicer-539 
dependent small RNAs derived from tRNAs. RNA 2009, 15, 2147-2160, 540 
doi:10.1261/rna.1738409. 541 
61. Gebetsberger, J.; Polacek, N. Slicing tRNAs to boost functional ncRNA diversity. RNA Biol 542 
2013, 10, 1798-1806, doi:10.4161/rna.27177. 543 
62. Anderson, P.; Ivanov, P. tRNA fragments in human health and disease. FEBS Lett 2014, 588, 544 
4297-4304, doi:10.1016/j.febslet.2014.09.001. 545 
Nutrients 2018, 10, x FOR PEER REVIEW  13 of 15 
 
63. Shen, Y.; Yu, X.; Zhu, L.; Li, T.; Yan, Z.; Guo, J. Transfer RNA-derived fragments and tRNA 546 
halves: biogenesis, biological functions and their roles in diseases. J Mol Med (Berl) 2018, 96, 547 
1167-1176, doi:10.1007/s00109-018-1693-y. 548 
64. Zhu, L.; Liu, X.; Pu, W.; Peng, Y. tRNA-derived small non-coding RNAs in human disease. 549 
Cancer Lett 2018, 419, 1-7, doi:10.1016/j.canlet.2018.01.015. 550 
65. Shigematsu, M.; Honda, S.; Kirino, Y. Transfer RNA as a source of small functional RNA. J 551 
Mol Biol Mol Imaging 2014, 1. 552 
66. Kiani, J.; Grandjean, V.; Liebers, R.; Tuorto, F.; Ghanbarian, H.; Lyko, F.; Cuzin, F.; 553 
Rassoulzadegan, M. RNA-mediated epigenetic heredity requires the cytosine 554 
methyltransferase Dnmt2. PLoS Genet 2013, 9, e1003498, doi:10.1371/journal.pgen.1003498. 555 
67. Cookson, W.; Liang, L.; Abecasis, G.; Moffatt, M.; Lathrop, M. Mapping complex disease 556 
traits with global gene expression. Nat Rev Genet 2009, 10, 184-194, doi:10.1038/nrg2537. 557 
68. Liu, Y.; Beyer, A.; Aebersold, R. On the Dependency of Cellular Protein Levels on mRNA 558 
Abundance. Cell 2016, 165, 535-550, doi:10.1016/j.cell.2016.03.014. 559 
69. Helm, M.; Motorin, Y. Detecting RNA modifications in the epitranscriptome: predict and 560 
validate. Nat Rev Genet 2017, 18, 275-291, doi:10.1038/nrg.2016.169. 561 
70. King, T.H.; Liu, B.; McCully, R.R.; Fournier, M.J. Ribosome structure and activity are altered 562 
in cells lacking snoRNPs that form pseudouridines in the peptidyl transferase center. Mol Cell 563 
2003, 11, 425-435. 564 
71. Liang, X.H.; Liu, Q.; Fournier, M.J. rRNA modifications in an intersubunit bridge of the 565 
ribosome strongly affect both ribosome biogenesis and activity. Mol Cell 2007, 28, 965-977, 566 
doi:10.1016/j.molcel.2007.10.012. 567 
72. Liang, X.H.; Liu, Q.; Fournier, M.J. Loss of rRNA modifications in the decoding center of the 568 
ribosome impairs translation and strongly delays pre-rRNA processing. RNA 2009, 15, 1716-569 
1728, doi:10.1261/rna.1724409. 570 
73. Jack, K.; Bellodi, C.; Landry, D.M.; Niederer, R.O.; Meskauskas, A.; Musalgaonkar, S.; 571 
Kopmar, N.; Krasnykh, O.; Dean, A.M.; Thompson, S.R., et al. rRNA pseudouridylation 572 
defects affect ribosomal ligand binding and translational fidelity from yeast to human cells. 573 
Mol Cell 2011, 44, 660-666, doi:10.1016/j.molcel.2011.09.017. 574 
74. Yoon, A.; Peng, G.; Brandenburger, Y.; Zollo, O.; Xu, W.; Rego, E.; Ruggero, D. Impaired 575 
control of IRES-mediated translation in X-linked dyskeratosis congenita. Science 2006, 312, 576 
902-906, doi:10.1126/science.1123835. 577 
75. Armistead, J.; Khatkar, S.; Meyer, B.; Mark, B.L.; Patel, N.; Coghlan, G.; Lamont, R.E.; Liu, S.; 578 
Wiechert, J.; Cattini, P.A., et al. Mutation of a gene essential for ribosome biogenesis, EMG1, 579 
causes Bowen-Conradi syndrome. Am J Hum Genet 2009, 84, 728-739, 580 
doi:10.1016/j.ajhg.2009.04.017. 581 
76. Warda, A.S.; Freytag, B.; Haag, S.; Sloan, K.E.; Gorlich, D.; Bohnsack, M.T. Effects of the 582 
Bowen-Conradi syndrome mutation in EMG1 on its nuclear import, stability and nucleolar 583 
recruitment. Hum Mol Genet 2016, 25, 5353-5364, doi:10.1093/hmg/ddw351. 584 
77. Wurm, J.P.; Meyer, B.; Bahr, U.; Held, M.; Frolow, O.; Kotter, P.; Engels, J.W.; Heckel, A.; 585 
Karas, M.; Entian, K.D., et al. The ribosome assembly factor Nep1 responsible for Bowen-586 
Conradi syndrome is a pseudouridine-N1-specific methyltransferase. Nucleic Acids Res 2010, 587 
38, 2387-2398, doi:10.1093/nar/gkp1189. 588 
Nutrients 2018, 10, x FOR PEER REVIEW  14 of 15 
 
78. Meyer, B.; Wurm, J.P.; Kotter, P.; Leisegang, M.S.; Schilling, V.; Buchhaupt, M.; Held, M.; 589 
Bahr, U.; Karas, M.; Heckel, A., et al. The Bowen-Conradi syndrome protein Nep1 (Emg1) 590 
has a dual role in eukaryotic ribosome biogenesis, as an essential assembly factor and in the 591 
methylation of Psi1191 in yeast 18S rRNA. Nucleic Acids Res 2011, 39, 1526-1537, 592 
doi:10.1093/nar/gkq931. 593 
79. Johansson, M.J.; Esberg, A.; Huang, B.; Bjork, G.R.; Bystrom, A.S. Eukaryotic wobble uridine 594 
modifications promote a functionally redundant decoding system. Mol Cell Biol 2008, 28, 595 
3301-3312, doi:10.1128/MCB.01542-07. 596 
80. Chen, C.; Tuck, S.; Bystrom, A.S. Defects in tRNA modification associated with neurological 597 
and developmental dysfunctions in Caenorhabditis elegans elongator mutants. PLoS Genet 598 
2009, 5, e1000561, doi:10.1371/journal.pgen.1000561. 599 
81. Blanco, S.; Dietmann, S.; Flores, J.V.; Hussain, S.; Kutter, C.; Humphreys, P.; Lukk, M.; 600 
Lombard, P.; Treps, L.; Popis, M., et al. Aberrant methylation of tRNAs links cellular stress 601 
to neuro-developmental disorders. EMBO J 2014, 33, 2020-2039, 602 
doi:10.15252/embj.201489282. 603 
82. Wei, F.Y.; Suzuki, T.; Watanabe, S.; Kimura, S.; Kaitsuka, T.; Fujimura, A.; Matsui, H.; Atta, 604 
M.; Michiue, H.; Fontecave, M., et al. Deficit of tRNA(Lys) modification by Cdkal1 causes the 605 
development of type 2 diabetes in mice. J Clin Invest 2011, 121, 3598-3608, 606 
doi:10.1172/JCI58056. 607 
83. Wei, F.Y.; Tomizawa, K. Functional loss of Cdkal1, a novel tRNA modification enzyme, 608 
causes the development of type 2 diabetes. Endocr J 2011, 58, 819-825. 609 
84. Zhou, B.; Wei, F.Y.; Kanai, N.; Fujimura, A.; Kaitsuka, T.; Tomizawa, K. Identification of a 610 
splicing variant that regulates type 2 diabetes risk factor CDKAL1 level by a coding-611 
independent mechanism in human. Hum Mol Genet 2014, 23, 4639-4650, 612 
doi:10.1093/hmg/ddu184. 613 
85. Carlile, T.M.; Rojas-Duran, M.F.; Zinshteyn, B.; Shin, H.; Bartoli, K.M.; Gilbert, W.V. 614 
Pseudouridine profiling reveals regulated mRNA pseudouridylation in yeast and human 615 
cells. Nature 2014, 515, 143-146, doi:10.1038/nature13802. 616 
86. Schwartz, S.; Bernstein, D.A.; Mumbach, M.R.; Jovanovic, M.; Herbst, R.H.; Leon-Ricardo, 617 
B.X.; Engreitz, J.M.; Guttman, M.; Satija, R.; Lander, E.S., et al. Transcriptome-wide mapping 618 
reveals widespread dynamic-regulated pseudouridylation of ncRNA and mRNA. Cell 2014, 619 
159, 148-162, doi:10.1016/j.cell.2014.08.028. 620 
87. Erales, J.; Marchand, V.; Panthu, B.; Gillot, S.; Belin, S.; Ghayad, S.E.; Garcia, M.; Laforets, F.; 621 
Marcel, V.; Baudin-Baillieu, A., et al. Evidence for rRNA 2'-O-methylation plasticity: Control 622 
of intrinsic translational capabilities of human ribosomes. Proc Natl Acad Sci U S A 2017, 114, 623 
12934-12939, doi:10.1073/pnas.1707674114. 624 
88. Marchand, V.; Blanloeil-Oillo, F.; Helm, M.; Motorin, Y. Illumina-based RiboMethSeq 625 
approach for mapping of 2'-O-Me residues in RNA. Nucleic Acids Res 2016, 44, e135, 626 
doi:10.1093/nar/gkw547. 627 
89. Zhang, Y.; Zhang, X.; Shi, J.; Tuorto, F.; Li, X.; Liu, Y.; Liebers, R.; Zhang, L.; Qu, Y.; Qian, J., 628 
et al. Dnmt2 mediates intergenerational transmission of paternally acquired metabolic 629 
disorders through sperm small non-coding RNAs. Nat Cell Biol 2018, 20, 535-540, 630 
doi:10.1038/s41556-018-0087-2. 631 
Nutrients 2018, 10, x FOR PEER REVIEW  15 of 15 
 
90. Legrand, C.; Tuorto, F.; Hartmann, M.; Liebers, R.; Jacob, D.; Helm, M.; Lyko, F. Statistically 632 
robust methylation calling for whole-transcriptome bisulfite sequencing reveals distinct 633 
methylation patterns for mouse RNAs. Genome Res 2017, 27, 1589-1596, 634 
doi:10.1101/gr.210666.116. 635 
91. Garalde, D.R.; Snell, E.A.; Jachimowicz, D.; Sipos, B.; Lloyd, J.H.; Bruce, M.; Pantic, N.; 636 
Admassu, T.; James, P.; Warland, A., et al. Highly parallel direct RNA sequencing on an array 637 
of nanopores. Nature methods 2018, 15, 201-206, doi:10.1038/nmeth.4577. 638 
92. Arava, Y.; Wang, Y.; Storey, J.D.; Liu, C.L.; Brown, P.O.; Herschlag, D. Genome-wide analysis 639 
of mRNA translation profiles in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 2003, 100, 640 
3889-3894, doi:10.1073/pnas.0635171100. 641 
93. Ingolia, N.T.; Ghaemmaghami, S.; Newman, J.R.; Weissman, J.S. Genome-wide analysis in 642 
vivo of translation with nucleotide resolution using ribosome profiling. Science 2009, 324, 218-643 
223, doi:10.1126/science.1168978. 644 
© 2018 by the authors. Submitted for possible open access publication under the terms and 645 
conditions of the Creative Commons Attribution (CC BY) license 646 
(http://creativecommons.org/licenses/by/4.0/). 647 
 648 
